BioAge Labs Inc. (BIOA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioAge Labs Inc.

    NASDAQ: BIOA · Real-Time Price · USD
    4.82
    -0.09 (-1.83%)
    At close: Sep 12, 2025, 12:55 PM

    BioAge Labs Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a
    Operating Income
    		 -78.19M -48.4M -39.97M
    Interest Income
    		 n/a 2.43M 465K
    Pretax Income
    		 -71.11M -63.85M -39.72M
    Net Income
    		 -71.11M -63.85M -39.72M
    Selling & General & Admin
    		 19.16M 14.51M 9.45M
    Research & Development
    		 59.04M 33.89M 30.52M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 78.19M 48.4M 39.97M
    Interest Expense
    		 n/a 7.79M 241K
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 n/a 48.4M 39.97M
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 10.73M 7.47M 7.46M
    Shares Outstanding (Diluted)
    		 10.73M 7.47M 7.46M
    EPS (Basic)
    		 -6.63 -8.55 -5.32
    EPS (Diluted)
    		 -6.63 -8.55 -5.32
    EBITDA
    		 -78.19M -55.9M -39.35M
    EBIT
    		 -68.74M -56.06M -39.48M
    Depreciation & Amortization
    		 -4.72M 162K 129K

    Add to Watchlist